跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRÁN ETEXILATO PENSA 110 MG CÁPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIGATRÁN ETEXILATO PENSA 110 MG CÁPSULAS DURAS EFG
Approved
STANDARD
DABIGATRÁN ETEXILATO PENSA 110 MG CÁPSULAS DURAS EFG
Towa Pharmaceutical S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 27, 2024
Approval ID
58675fc306963185
Company
Towa Pharmaceutical S.A.
Type
Standard
Approval Details
Approval Id
58675fc306963185
Drug Cima Aemps Name
DABIGATRÁN ETEXILATO PENSA 110 MG CÁPSULAS DURAS EFG
Register Number
89467
Holder Company Name
Towa Pharmaceutical S.A.
Marketing Company Name
Towa Pharmaceutical S.A.
Authorization Date
2024-03-27
Dosage Form
CÁPSULA DURA
Dose
110 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Towa Pharmaceutical S.A.
Active Ingredients
DABIGATRAN ETEXILATO MESILATO
126,83 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 27, 2024
Approval ID
58675fc306963185
Type
Standard
Back to CIMA-AEMPS Approvals
